The year isn’t kicking off on a great note for Johnson & Johnson (NYSE: JNJ). While the broader market has performed pretty well since early January, shares of the healthcare giant have dropped by 6%. Johnson & Johnson is facing issues that are causing investors to look e…
Read More
About The Author
